Our recent studies revealed that mTOR inhibitors such as rapamycin and temsirolimus increase Akt phosphorylation/activation and cyclin D1 expression levels in pancreatic cancer cells [16]. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.